Plasma pharmacokinetics of tigolaner, emodepside, and praziquantel following topical administration of a combination product (Felpreva®) and of intravenous administration of the individual active ingredients in cats
Felpreva® for cats contains the new acaricidal/insecticidal active ingredient tigolaner in a fixed combination with the nematocidal and cestocidal compounds emodepside and praziquantel, respectively. The plasma pharmacokinetics of tigolaner, emodepside, and praziquantel were evaluated in clinically...
Main Authors: | Norbert Mencke, Wolfgang Bäumer, Kristine Fraatz, Ralph Krebber, Marc Schneider, Katrin Blazejak |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Current Research in Parasitology and Vector-Borne Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667114X23000146 |
Similar Items
-
Efficacy of Felpreva®, a new spot-on formulation containing tigolaner, emodepside and praziquantel, applied as a single application to cats artificially infested with ear mites (Otodectes cynotis)
by: Katrin Blazejak, et al.
Published: (2023-01-01) -
Immediate and long-term efficacy of Felpreva®, a new spot-on formulation containing tigolaner, emodepside and praziquantel, applied as a single application to cats artificially infested with the cat flea Ctenocephalides felis
by: Norbert Mencke, et al.
Published: (2023-01-01) -
Efficacy and safety of Felpreva®, a spot-on formulation for cats containing emodepside, praziquantel and tigolaner against experimental infestation with the Australian paralysis tick Ixodes holocyclus
by: Florian Roeber, et al.
Published: (2023-01-01) -
Multicenter randomized, and blinded European field study evaluating the efficacy and safety of Felpreva®, a novel spot-on formulation containing emodepside, praziquantel and tigolaner, in treating cats naturally infested with fleas and/or ticks
by: Dejan Cvejić, et al.
Published: (2022-01-01) -
Efficacy of two topical combinations containing emodepside plus praziquantel, and emodepside plus praziquantel plus tigolaner, for the treatment of troglostrongylosis in experimentally infected cats
by: Donato Traversa, et al.
Published: (2022-01-01)